Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
A survey of biopharmaceutical dealmakers by Campbell Alliance, the consulting firm of inVentiv Health, suggests that 2015 will set a new record for mergers and acquisitions and licensing of biopharmaceutical assets.
read more
Wednesday, March 02, 2016
SubjectWell, a provider of a risk-free patient recruitment marketplace for clinical trials, today announced the release of their report on consumer perceptions of clinical trials. The SubjectWell Survey of Clinical Trial Awareness and Attitudes ...
read more
Wednesday, November 30, 2016
Supply Chain Wizard, a full-service global consulting firm specializing in serialization and traceability, as well as supply chain strategy and operational transformation programs – is co-hosting the Pharma CMO Summit on December 12, 2016 at the ...
read more
Wednesday, September 20, 2017
Supply Chain Wizard has opened a new UK-Ireland office in London, and a new Latin American office in Miami.
read more
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that Dr. M. James Barrett, Ph.D., has resigned from its ...
read more
Wednesday, December 30, 2020
SAI is voluntarily recalling Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level.
read more
Tuesday, December 29, 2015
Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, announced that it has acquired all of the remaining rights, title and interest in and ...
read more
SunGen Pharma announced the launch of Busulfan Injection, the second product launch through their joint venture Peterson Athenex with Athenex Pharmaceuticals.
read more
Monday, September 16, 2019
SunGen Pharma has received its seventh ANDA approval from the US Food and Drug Administration.
read more
Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab.
read more
Wednesday, November 28, 2018
Sun Pharmaceutical has entered into a definitive agreement to acquire Pola Pharma, a Japanese pharmaceutical company engaged in research and development, manufacture, sale and distribution of branded and generic products in Japan.
read more
Wednesday, December 26, 2018
DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera from using DUSA's confidential and proprietary trade secret information.
read more
Wednesday, February 26, 2020
Sun Pharmaceutical has launched Riomet ER™ in the U.S. to improve glycemic control in patients 10 years of age and older with type 2 diabetes mellitus.
read more
Sun announced INFUGEM™, for intravenous use, is now commercially available in the U.S.
read more
Sun Pharmaceutical announced the U.S. launch of Ezallor Sprinkle™ capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing.
read more